TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING
Clinical trials for TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING explained in plain language.
Never miss a new study
Get alerted when new TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING trials appear
Sign up with your email to follow new studies for TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough breast cancer: immune booster after chemo may keep cancer away
Disease control Not yet recruitingThis study tests whether adding the immunotherapy drug pembrolizumab to usual post-surgery treatment can help prevent breast cancer from returning in people with early-stage triple-negative breast cancer who still had cancer after initial chemo and pembrolizumab. About 1,000 adul…
Matched conditions: TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING
Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Gut check: could your microbiome predict cancer treatment success?
Knowledge-focused Not yet recruitingThis study looks at how diet and gut bacteria affect treatment outcomes in women with early-stage triple-negative breast cancer. Researchers will collect stool, blood, and tumor samples from 300 participants before, during, and after chemotherapy and immunotherapy. The goal is to…
Matched conditions: TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING
Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC